After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023
Pharmaceutical Technology
MAY 26, 2023
Pharma company merger and acquisition (M&A) activity in the first half of 2023 has remained relatively low, consistent with the second half of last year, but investors predict deals will increase later in 2023. Experts at PWC, Goldman Sachs, and Morgan Stanley agree that pharma-related M&A is expected to pick up in 2023.
52 
Let's personalize your content